Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic and Topical Treatments for Erlotinib-Induced Rash in NSCLC
NCT00473083Phase 2Completed
- Sponsor
- BC Cancer
- Start
- Jan 2009
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of minocycline, clindamycin + hydrocortisone, sponsored by BC Cancer. Started Jan 2009; status: completed.
02
Drugs
minocyclineclindamycin + hydrocortisone
Beyond the preview
Go deeper on NCT00473083.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00473083.